Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Study provides new data on discontinuation of active surveillance by low-risk prostate cancer patients

Nearly half of men initially managed with active surveillance for "low-risk" prostate cancer transition to definitive treatment – such as surgery or radiation therapy – within a few years after diagnosis.

23 Aug 2021

Researchers identify genes associated with biochemical recurrence in prostate adenocarcinoma

Aging-US published "Identification of microenvironment related potential biomarkers of biochemical recurrence at 3 years after prostatectomy in prostate adenocarcinoma" which reported that the authors aimed to identify the potential prognostic genes in the prostate adenocarcinoma microenvironment and to estimate the causal effects simultaneously.

20 Aug 2021

Prostate cancer survivors have persistent fear of cancer recurrence, study reveals

A recent study reveals that some prostate cancer survivors have a persistent fear of cancer recurrence even many years after diagnosis and treatment.

19 Aug 2021

Patients with enlarged prostate may have lower chances of significant prostate cancer

A team of Beaumont Health researchers from Radiology, Radiation Oncology and Urology studied the relationship between benign prostatic hyperplasia, or BPH, and prostate cancer in 405 men by quantitatively looking at different parts of prostate tissue on MRI.

18 Aug 2021

Novel blood test as adjunct to MRI improves prostate cancer screening

Researchers at Karolinska Institutet in Sweden recently reported that magnetic resonance imaging (MRI) could reduce overdiagnoses and thereby improve prostate cancer screening.

12 Aug 2021

Widowhood associated with greater risk of advanced prostate cancer

Social environment is a key factor in the risk of developing prostate cancer. PhD student Charlotte Salmon and Professor Marie-Élise Parent of Institut national de la recherche scientifique (INRS) have shown that widowers are more likely to be diagnosed with advanced prostate cancer.

12 Aug 2021

Many men with prostate cancer may be making treatment choices without understanding all options

One of the bi-products of the COVID-19 pandemic has been a decrease in the number of patients seeing or talking to their GPs, as findings from a Institute of Fiscal Studies report identified late last year.

6 Aug 2021

Hormone-resistant prostate, breast cancers added to clinical trial of experimental DNA therapy

The Republic of Belarus Ministry of Health has approved expanding the ongoing clinical trial of CureLab Oncology's Elenagen, an experimental DNA therapy, to include two new arms: 1) hormone-resistant breast cancer; and 2) hormone-resistant metastatic prostate cancer.

3 Aug 2021

Study reveals effective strategy to extend the benefit of immunotherapy for prostate cancer

It's a scientific riddle tangled up in a complex web. How do you turn an immune cold cancer into one that responds to immunotherapy?

2 Aug 2021

Genomic test may help identify prostate cancer patients at high risk of disease progression

After a biopsy comes back positive for prostate cancer, patients and their doctors are often left with a choice between taking a watch-and-wait approach, known as active surveillance, or proceeding with surgery or radiation.

27 Jul 2021

New radiotracer opens the door for advancement of iron-targeted cancer therapies

A new radiotracer that detects iron in cancer cells has proven effective, opening the door for the advancement of iron-targeted therapies for cancer patients.

23 Jul 2021

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

RedHill Biopharma Ltd., a specialty pharma company that is a leader in the development of novel oral therapies for COVID-19, today announced that all treatment and follow-up has now been completed in the 475-patient global Phase 2/3 study with opaganib (ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840). Top-line results are expected in the coming weeks.

20 Jul 2021

A low-cost biopolymer dressing to help heal chronic wounds

Tens of millions of patients around the world suffer from persistent and potentially life-threatening wounds. These chronic wounds, which are also a leading cause of amputation, have treatments, but the cost of existing wound dressings can prevent them from reaching people in need.

19 Jul 2021

MRI screening and targeted biopsies could reduce overdiagnoses of prostate cancer

Most countries have not introduced nationwide prostate-cancer screening, as current methods result in overdiagnoses and excessive and unnecessary biopsies. A new study by researchers at Karolinska Institutet in Sweden, which is published in The New England Journal of Medicine, indicates that screening by magnetic resonance imaging (MRI) and targeted biopsies could potentially cut overdiagnoses by half.

9 Jul 2021

Research reveals recovery of cancer screening tests and associated disparities after first pandemic peak

The numbers of cancer screening tests rebounded sharply in the last quarter of 2020, following a dramatic decline in the first months of the COVID-19 pandemic, at one large hospital system in the Northeastern United States. These findings were released in a study published in Cancer Cell.

8 Jul 2021

Anti-androgen therapy for patients with advanced prostate cancer may fuel bone metastasis

Dr Bock, under the mentorship of Distinguished Professor Dietmar Hutmacher, from QUT Centre for Biomedical Technologies, has focused her research on bone metastases from breast and prostate cancers.

7 Jul 2021

Artificial intelligence program analyzes CT scans for tell-tale signs of prostate cancer

Prostate cancer is the most diagnosed cancer and a leading cause of death by cancer in Australian men.

7 Jul 2021

Multimodality therapy critical for treating more aggressive prostate cancers

Men with high-risk prostate cancer with at least one additional aggressive feature have the best outcomes when treated with multiple healthcare disciplines, known as multimodality care, according to a UCLA study led by Dr. Amar Kishan, assistant professor of radiation oncology at the David Geffen School of Medicine at UCLA and a researcher at the UCLA Jonsson Comprehensive Cancer Center.

1 Jul 2021

Black male veterans more likely to receive radiation or surgery for prostate cancer than non-Black men

Black men most likely to benefit from advanced prostate cancer therapies are 11 percent less likely to get them than non-Black men. This happens despite apparent equal opportunities in obtaining health care services, a new study in American veterans shows

29 Jun 2021

Study explores the potential role of gene polymorphisms in pathogenesis of prostate cancer

Oncotarget published "The presence of polymorphisms in genes controlling neurotransmitter metabolism and disease prognosis in patients with prostate cancer: a possible link with schizophrenia" reported that polymorphisms of neurotransmitter metabolism genes were studied in patients with prostate cancer (PC) characterized by either reduced or extended serum prostate-specific antigen doubling time corresponding to unfavorable and favorable disease prognosis respectively.

28 Jun 2021

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Study provides new data on discontinuation of active surveillance by low-risk prostate cancer patients

Researchers identify genes associated with biochemical recurrence in prostate adenocarcinoma

Prostate cancer survivors have persistent fear of cancer recurrence, study reveals

Patients with enlarged prostate may have lower chances of significant prostate cancer

Novel blood test as adjunct to MRI improves prostate cancer screening

Widowhood associated with greater risk of advanced prostate cancer

Many men with prostate cancer may be making treatment choices without understanding all options

Hormone-resistant prostate, breast cancers added to clinical trial of experimental DNA therapy

Study reveals effective strategy to extend the benefit of immunotherapy for prostate cancer

Genomic test may help identify prostate cancer patients at high risk of disease progression

New radiotracer opens the door for advancement of iron-targeted cancer therapies

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

A low-cost biopolymer dressing to help heal chronic wounds

MRI screening and targeted biopsies could reduce overdiagnoses of prostate cancer

Research reveals recovery of cancer screening tests and associated disparities after first pandemic peak

Anti-androgen therapy for patients with advanced prostate cancer may fuel bone metastasis

Artificial intelligence program analyzes CT scans for tell-tale signs of prostate cancer

Multimodality therapy critical for treating more aggressive prostate cancers

Black male veterans more likely to receive radiation or surgery for prostate cancer than non-Black men

Study explores the potential role of gene polymorphisms in pathogenesis of prostate cancer

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in